Then our clinical study confirmed the relationship between IBD and hyperglycemia that the serum level of intestinal fatty acid-binding protein, a biomarker of IBD, was positively associated with the duration of hyperglycemia in T2D patients, with further investigation suggesting that the IBD worsened with the progression of T2D (4). This evidence concerns the gene FABP2 and Hyperglycemia.